ArticleCureus2023

Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.

Atif A Hashmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.